Meyers & Flowers warns those with Gout about an increased risk of death from Uloric
Meyers & Flowers is alerting patients with gout about a new Boxed Warning being added to Takeda Pharmaceuticals’ Uloric.
The recent safety announcement comes after a long-term study comparing Uloric to allopurinol found an increased risk of heart-related death and death from all causes with Uloric. The FDA is also limiting the approved use of Uloric to only certain patients who are not treated effectively or experience severe side effects with allopurinol.
Gout is a serious and common form of arthritis that affects more than 8.3 million Americans. Gout occurs as high levels of uric acid build up and form needle-like urate crystals in the joints. The result is painful swelling and redness of the joints, often starting in the big toe but also affecting in the knees, elbows, ankles, and fingers.
The body produces uric acid to break down purines which are natural substances found in the body. In most cases, the uric acid will dissolve into the blood and pass through the kidneys and into the urine. However, when the body produces either too much uric acid or the kidneys are unable to excrete too little uric acid, gout develops.
The FDA is warning gout patients taking Uloric to seek immediate medical attention if they begin to experience any of the following:
- Chest pain or Shortness of breath
- Rapid or irregular heartbeat
- Numbness or weakness on one side of your body
- Dizziness or trouble talking
- Sudden severe headache
The agency is limiting the use of Uloric to patients who are not able to be treated effectively or have experienced severe side effects with allopurinol.
Meyers & Flowers has seen the destruction dangerous drugs such as Uloric can cause and how devastating it can be on patients and their families. This is why we are dedicated to taking on companies such as Takeda Pharmaceuticals.
If you or a family member have been injured or killed due to taking Uloric for gout, Meyers & Flowers can help you explore your legal options. We can be reached at email@example.com or at 877-221-2511.